Clinical Trial Update: Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating irofulven in patients with persistent or recurrent endometrial cancer. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Irofulven (irofulven)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED